Cleared Traditional

K900671 - HARE EMERGENCY STRETCHER WITH WHEELS

K900671 is an FDA 510(k) clearance for HARE EMERGENCY STRETCHER WITH WHEELS, manufactured by Dyna Corp.. The device is a Class 1 General Hospital device with product code FPP cleared through the Traditional 510(k) pathway after a 69-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1990
Decision
69d
Days
Class 1
Risk

K900671 is an FDA 510(k) clearance for the HARE EMERGENCY STRETCHER WITH WHEELS. Classified as Stretcher, Hand-carried (product code FPP), Class I - General Controls.

Submitted by Dyna Corp. (Carlsbad, US). The FDA issued a Cleared decision on April 23, 1990 after a review of 69 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.6900 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Dyna Corp. devices

FDA 510(k) Submission Details - K900671

510(k) Number K900671 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 13, 1990
Decision Date April 23, 1990
Days to Decision 69 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
60d faster than avg
Panel avg: 129d · This submission: 69d
Pathway characteristics
Predicate-based equivalence.

FPP Device Classification - Class 1, General Controls

Product Code FPP Stretcher, Hand-carried
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 880.6900
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.